|
Volumn 30, Issue 2, 2002, Pages 148-154
|
Biotransformation of L-cysteine S-conjugates and N-acetyl-L-cysteine S-conjugates of the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vlnyl ether (compound A) in human kidney in vitro: Interindividual variability in N-acetylation, N-deacetylation, and Β-lyase-catalyzed metabolism
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2,2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL FLUOROMETHYL ETHER;
6 MERCAPTOPURINE DERIVATIVE;
ALKENE DERIVATIVE;
ANESTHETIC AGENT;
CYSTEINE;
CYSTEINE DERIVATIVE;
GLUTATHIONE PEROXIDASE;
HALOOLEFIN;
LYASE;
SEVOFLURANE;
ANIMAL CELL;
ANIMAL EXPERIMENT;
ARTICLE;
DEACETYLATION;
DRUG ACETYLATION;
DRUG DEGRADATION;
DRUG METABOLISM;
DRUG TRANSFORMATION;
GENETIC VARIABILITY;
HUMAN;
HUMAN TISSUE;
KIDNEY METABOLISM;
NEPHROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
ACETYLATION;
ACETYLCYSTEINE;
ANESTHETICS, INHALATION;
BIOTRANSFORMATION;
CYSTEINE;
ETHERS;
FREE RADICAL SCAVENGERS;
HUMANS;
HYDROCARBONS, FLUORINATED;
KIDNEY;
LYASES;
METHYL ETHERS;
ANIMALIA;
|
EID: 0036148606
PISSN: 00909556
EISSN: None
Source Type: Journal
DOI: 10.1124/dmd.30.2.148 Document Type: Article |
Times cited : (21)
|
References (39)
|